Keryx Biopharmaceuticals Inc.

(KERX) Trade

By |

Profile

Keryx Biopharmaceuticals Inc focuses on developing medicines to people with kidney diseases. The marketed product of the company is auryxia tablet, which is a iron based medicine.

Contact Information

Website: www.keryx.com
Email: IR@keryx.com
Main Phone: +1 617 466-3500
Address: One Marina Park Drive, 12th Floor
State: MA
City / Town: Boston
Country: USA
Postal Code: 02210

Issuer Information

Exchange: NSC
CEO: Jodie P. Morrison
Employees: 207
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 4.48 $ -0.05 (-1.10%)
Last Price 4.48 Change $ -0.05 Change % -1.10 Tick N/A
Bid 3.56 Bid Size 2,000.00 Ask 4.70 Ask Size 2,000.00
Open 4.55 High 4.64 Low 4.40 Prev Close 4.53
Last Trade Volume 1.1 mi 52 Wk Hi 8.07 52 Wk Low 3.30
Market Cap 539.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 120,378,658.00 EPS (TTM) -1.40 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 13 42
Number of Buys 4 5
Number of Sells 9 37
Net Activity 262745 249536
Last 10 Buys Shares
Scott A Holmes 1,000
Scott A Holmes 1,000
Scott A Holmes 1,000
Greg Madison 1,000
John F. Neylan 1,000
Michael P. Tarnok 1,000
Greg Madison 1,000
Ron Bentsur 1,000
Ron Bentsur 1,000
Joseph M. Feczko 1,000
Last 10 Sell Shares
Steven C. Gilman 1,000
Steven C. Gilman 1,000
Kevin J. Cameron 1,000
John F. Neylan 1,000
Scott A Holmes 1,000
John F. Neylan 1,000
Scott A Holmes 1,000
John F. Neylan 1,000
Christine A Carberry 1,000
Brian Adams 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 6.67 6.67 6.67 6.67
Standard Deviation 1.37 1.37 1.37 1.37
Date of Most Recent Estimate 05/25/18 05/25/18 05/14/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.17 2.17 2.17 2.17